Vaccine for eliciting immune response comprising RNA encoding an immunogen and lipid formulations comprising mole percentage of lipids | Patent Publication Number 20220362152

US 20220362152 A1
Patent NumberUS 11638693 B2
Application Number17808519
Filled DateJun 23, 2022
Priority DateJul 6, 2010
Publication DateNov 17, 2022
Original AssigneeGlaxo Group Limited
Current AssigneeGlaxo Group Limited
Inventor/ApplicantsAndrew Geall
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.